Close

Genes-Drugs

last updated 01/5/2017

CPIC assigns CPIC levels to genes/drugs with (1) PharmGKB Clinical Annotation Levels of Evidence of 1A, 1B, 2A and 2B, or (2) a PharmGKB PGx level for FDA-approved drug labels of “actionable pgx”, “genetic testing recommended”, or “genetic testing required”, or (3) based on nomination to CPIC for consideration.

CPIC invites feedback on existing and planned gene/drug guidelines.

Download Table (CSV)